Trial Profile
A pharmacokinetic and pharmacodynamic study of Dexmedetomidine in patients with end-stage renal failure and secondary hyperparathyroidism undergoing general anaesthesia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Mar 2016
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Sedation
- Focus Pharmacodynamics; Pharmacokinetics
- 02 Mar 2016 New trial record